|
|
Aclarion Inc
ACON's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Aclarion Inc 's sales fell
by -62.74 % in IV. Quarter 2022 from the same quarter a year ago.
Ranking at No. 395
Medical Laboratories industry recorded
deterioration of revenues by -1.95 %
Aclarion Inc net loss deacreased by in IV. Quarter 2022 year on year, Aclarion Inc net loss increased by -82.53 % in IV. Quarter 2022 year on year,
• More on ACON's Growth
|
|
Aclarion Inc
reported net loss of -8 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
19.6 |
|
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.11.
• More on ACON's Valuation
|
|
|
|
|
Aclarion Inc
reported net loss of -8 millions in the past twelve months.
|
| Company |
| |
|
PE TTM
|
| Industry |
|
19.6 |
|
PE TTM
|
|
Medical Laboratories industry's Price to Sales ratio is at 2.11.
| | | |
